EX-10.1 2 dex101.htm DEVELOPMENT, OPTION AND LICENSE AGREEMENT DEVELOPMENT, OPTION AND LICENSE AGREEMENTDevelopment, Option and License Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020THIS DEVELOPMENT, OPTION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of the 15th day of May, 2003 (the “Effective Date”), by and between POZEN INC., a Delaware corporation, located at 1414 Raleigh Road, Suite 400, Chapel Hill, NC 27517 on behalf of itself and its Affiliates (collectively “POZEN”), and NYCOMED DANMARK APS, a Danish corporation, located at Langebjerg 1, DK-4000 Roskilde, Denmark on behalf of itself and its Affiliates (collectively “Nycomed”). POZEN and Nycomed are referred to in this Agreement individually as a “Party” and collectively as “Parties.”
DEVELOPMENT, OPTION AND LICENSE AGREEMENTDevelopment, Option and License Agreement • July 28th, 2005 • Pozen Inc /Nc • Pharmaceutical preparations
Contract Type FiledJuly 28th, 2005 Company Industry